Advertisement

Topics

Sandoz International GmbH Company Profile

06:43 EST 12th December 2018 | BioPortfolio

Sandoz, a Novartis company, is a world leader in generic pharmaceuticals. The company develops, manufactures and markets these medicines as well as pharmaceutical and biotechnological active ingredients.In 2005, Sandoz acquired Hexal, one of Germany’s leading generics company, and Eon Labs, one of the fastest-growing generic pharmaceuticals companies in the US. These acquisitions significantly strengthen the Sandoz technology base, particularly in the application of “difficult-to-make” generics: transdermal patches, inhalation products, sustained-release implants and multi-particulate drug-delivery dosage forms. Also expanded are the traditionally strong capabilities in pharmaceuticals, biopharmaceuticals and anti-infectives.

Location

Industriestrasse 25
Holzkirchen
83607
Germany

Contact

Phone: 49 (0) 8024 476 0
Fax: 49 (0) 8024 476-2599
Email: info.sandoz@sandoz.com


News Articles [809 Associated News Articles listed on BioPortfolio]

Sandoz International GmbH Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175

Sandoz International GmbH Strategy, SWOT and Corporate Finance ReportSummarySandoz International GmbH Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and infor...

Sandoz becomes first Canadian pharmaceutical company to enter medical cannabis field

Subsidiary of Sandoz International, Sandoz Canada, has finalised its alliance with Health Canada-licensed medical cannabis producer Tilray to improve Canadians’...Read More... The post Sandoz become...

Novartis International AG: Sandoz receives US FDA approval for biosimilar Hyrimoz (adalimumab-adaz)

Novartis International AG / Sandoz receives US FDA approval for biosimilar Hyrimoz (adalimumab-adaz) . Processed and transmitted by West Corporation. The issuer is solely responsible for the conten...

Novartis International AG: Sandoz receives European Commission approval for biosimilar Hyrimoz (adalimumab)

Novartis International AG / Sandoz receives European Commission approval for biosimilar Hyrimoz (adalimumab) . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsi...

Janssen Affiliate Cilag GmbH International Enters Worldwide Collaboration and License Agreement ...

ZUG, Switzerland, December 3, 2018 /PRNewswire/ -- Cilag GmbH International, an affiliate of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today it has Read more...

Novartis International AG: Sandoz Inc. and Pear Therapeutics Obtain FDA Clearance for reSET-O to Treat Opioid Use Disorder

Novartis International AG / Sandoz Inc. and Pear Therapeutics Obtain FDA Clearance for reSET-O to Treat Opioid Use Disorder . Processed and transmitted by West Corporation. The issuer is solely res...

Novartis International AG: Sandoz announces global resolution of biosimilar adalimumab patent disputes, securing patient access

Novartis International AG / Sandoz announces global resolution of biosimilar adalimumab patent disputes, securing patient access . Processed and transmitted by West Corporation. The issuer is solel...

Sandoz Canada launches (Pr)Sandoz Levetiracetam® 1000 mg tablets as an adjunctive treatment of epilepsy

Sandoz Canada is the first company in Canada to offer levetiracetam in the higher concentration 1000 mg, enabling patients to reduce the number of tablets they need to take daily.PrSandoz Levetiracet...

PubMed Articles [500 Associated PubMed Articles listed on BioPortfolio]

Long-term Challenges After Solid Organ Transplantation: Summary of Expert Presentations From the Sandoz 5th Standalone Transplantation Meeting, 2017.

Evaluation of the real-world impact of rotational thromboelastometry-guided transfusion protocol in patients undergoing proximal aortic surgery.

Complex aortic procedures are potentially associated with important blood loss and coagulopathy. The aim of this study was to assess the impact of rotational thromboelastometry (ROTEM, Tem Internation...

A comparison of different farrowing systems - Part 1: Effects on the activity of the sow.

The aim of this study was to determine whether a 3-axis accelerometer (MSR 145B V5.106, MSR Electronics GmbH, Seuzach, Switzerland) can continuously record and display the activity behaviour of sows o...

A purpose-designed monofilament-fibre pad for debridement of hard-to-reach wounds: experience in clinical practice.

Effective and comfortable debridement is an important part of managing complex wounds. This user test evaluated a monofilament-fibre pad (with handle) (Debrisoft Lolly, Lohmann & Rauscher GmbH & Co. K...

Field study on loose farrowing in cold barns.

The aim of this field study was to examine the loose farrowing system in view of practicability, particularly to monitor piglet losses and their causes, on a farm proceeding in accordance with the BIO...

Clinical Trials [1139 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

A Study Comparing Two Rifaximin Tablets in Patients With Travelers' Diarrhea.

This study will compare safety and efficacy of a generic rifaximin tablet to the reference listed drug in the treatment of travelers' diarrhea. Additionally both the generic and reference ...

To Demonstrate the Relative Bioavailability of Cefzil 500 mg Cefprozil Tablets Under Fed Conditions

The purpose of this study is to Demonstrate the Relative Bioavailability of Cefzil 500 mg Cefprozil Tablets Under Fed Conditions.

To Demonstrate the Relative Bioavailability of Cefzil 500 mg Cefprozil Tablets Under Fasting Conditions

To demonstrate the relative bioavailability of Cefzil 500 mg Cefprozil tablets under fasting conditions.

To Demonstrate the Relative Bioavailability of Cefzil 250 mg/5 ml Cefprozil Oral Suspension Following a 10 ml Dose Fasting Conditions.

The purpose of this study is to Demonstrate the Relative Bioavailability of Cefzil 250 mg/5 ml Cefprozil Oral Suspension Following a 10 ml Dose Fasting Conditions.

Companies [1823 Associated Companies listed on BioPortfolio]

Sandoz GmbH

Nil

Lek Ljubljana Holding GmbH

Lek, a Sandoz company, is one of the pillars of leading world generics company Sandoz. It operates as a global development center for products and technologies, as a global manufacturing center for ac...

Sandoz Inc.

Sandoz, a Division of the Novartis group, is a global leader in the field of generic pharmaceuticals, offering a wide array of high-quality, affordable products that are no longer protected by patents...

Sandoz International GmbH

Sandoz, a Novartis company, is a world leader in generic pharmaceuticals. The company develops, manufactures and markets these medicines as well as pharmaceutical and biotechnological active ingredien...

Ormecon GmbH

Ormecon GmbH, with its location in Ammersbek/Germany, is the headquarter of Ormecon International. Ormecon GmbH was originally founded as "Ormecon Chemie GmbH & Co. KG" in 1996, as a 100% subsidiary o...

More Information about "Sandoz International GmbH" on BioPortfolio

We have published hundreds of Sandoz International GmbH news stories on BioPortfolio along with dozens of Sandoz International GmbH Clinical Trials and PubMed Articles about Sandoz International GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sandoz International GmbH Companies in our database. You can also find out about relevant Sandoz International GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record